We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAX:NYSEMediaAlpha, Inc. Analysis

Data as of 2026-06-21 - not real-time

$10.13

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

MediaAlpha, Inc. trades around $10.13, well below its DCF-derived fair value of roughly $28, implying a substantial upside potential. The stock’s forward PE of about 6x versus a trailing PE of 16x highlights earnings acceleration and a compelling valuation gap. Technical signals are mixed: a bullish MACD histogram and an RSI near 65 suggest lingering momentum, yet the 20‑day SMA sits just under the 50‑day SMA and the trend is flagged bearish, placing the price close to a support zone near $8.06. Volatility is elevated at nearly 48% over the past month, and the beta around 0.7 indicates modest market sensitivity, but the ongoing securities‑law investigation into alleged deceptive advertising adds a pronounced regulatory headwind. Revenue is expanding at ~17% year‑over‑year, though margins remain thin, and the company carries a modest debt load with ample cash. Given the combination of strong upside, growth metrics, and heightened regulatory risk, the investment case is nuanced and time‑sensitive.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Pending regulatory investigation creates uncertainty
  • Bullish MACD and upside potential from DCF valuation
  • Bearish SMA crossover and high short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth of ~17% and low forward PE support earnings upside
  • DCF fair value indicating ~35% upside
  • Improving technical momentum as volume trends upward

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained growth in insurance acquisition platform revenues
  • Undervalued valuation relative to industry peers
  • Potential resolution of regulatory issues enhancing credibility

Key Metrics & Analysis

Financial Health

Revenue Growth17.30%
Profit Margin3.37%
P/E Ratio15.8
ROA16.43%
P/B Ratio289.4
Op. Cash Flow$40.3M
Free Cash Flow$61.6M
Industry P/E16.7

Technical Analysis

TrendBearish
RSI64.7
Support$8.06
Resistance$10.26
MA 20$9.14
MA 50$9.18
MA 200$10.69
MACDBullish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Fair Value$28.06
Target Price$13.71
Upside/Downside35.38%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.70
Volatility47.74%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.